Philipp Mann

6PUBLICATIONS
36CO-AUTHORS
Pacific Peoples theory of change models for healthInnate immunityNanomedicineReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 26, 2026
Safety and immunogenicity of an mRNA COVID-19 vaccine administered to adults: A phase 2, randomized, active-controlled trial.

|Feb 17, 2026
Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study.

Isabel Leroux-Roels, Ilse De Coster, Alberto M Borobia

|Nov 28, 2024
Enhanced and sustained biodistribution of HIV-1 neutralizing antibody VRC01LS in human genital and rectal mucosa.

Maria P Lemos, Rena D Astronomo, Yunda Huang

|Oct 18, 2024
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.

Brandon J Essink, Craig Shapiro, Marie Grace Dawn Isidro

|Apr 27, 2024
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity.

Olaf-Oliver Wolz, Dominik Vahrenhorst, Gianluca Quintini

|Apr 23, 2022
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant.

Olaf-Oliver Wolz, Sarah-Katharina Kays, Helga Junker

Pageof 1

Frequent Collaborators

3 joint publications

Olaf-Oliver Wolz

2 joint publications

Stefano Berrè

2 joint publications

Martin Robert Gaudinski

2 joint publications

Tapiwa Ganyani